Financials
- Market Capitalization 3.73 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1528 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.89 USD | +1.83% | -5.52% | +8.69% | -6.56% | 3.96 B USD | ||
| 1533 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.49 USD | +0.03% | -0.03% | +0.41% | +48.47% | 3.85 B USD | ||
| 1556 | DNLI Denali Therapeutics Inc. - Common Stock | 22.71 USD | -14.24% | -13.91% | +3.89% | +40.45% | 3.60 B USD | ||
| 1573 | GPCR Structure Therapeutics Inc - American Depositary Shares | 50.88 USD | -1.47% | -10.06% | +18.33% | +90.28% | 3.62 B USD |